News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
572,341 Results
Type
Article (46871)
Company Profile (125)
Press Release (525345)
Multimedia
Podcasts (85)
Webinars (11)
Section
Business (155500)
Career Advice (2801)
Deals (29626)
Drug Delivery (117)
Drug Development (67638)
Employer Resources (163)
FDA (14788)
Job Trends (13788)
News (276824)
Policy (30274)
Tag
Academia (2635)
Academic (2)
Accelerated approval (6)
Adcomms (23)
Allergies (82)
Alliances (40524)
ALS (96)
Alzheimer's disease (1348)
Antibody-drug conjugate (ADC) (123)
Approvals (14774)
Artificial intelligence (259)
Autoimmune disease (27)
Automation (16)
Bankruptcy (298)
Best Places to Work (10531)
BIOSECURE Act (21)
Biosimilars (112)
Biotechnology (87)
Bladder cancer (81)
Brain cancer (29)
Breast cancer (258)
Cancer (2157)
Cardiovascular disease (192)
Career advice (2338)
Career pathing (32)
CAR-T (151)
Cell therapy (406)
Cervical cancer (18)
Clinical research (55362)
Collaboration (762)
Company closure (1)
Compensation (233)
Complete response letters (25)
COVID-19 (2604)
CRISPR (42)
C-suite (220)
Cystic fibrosis (86)
Data (2056)
Decentralized trials (2)
Denatured (19)
Depression (50)
Diabetes (268)
Diagnostics (6213)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (39)
Drug discovery (120)
Drug pricing (119)
Drug shortages (31)
Duchenne muscular dystrophy (90)
Earnings (57376)
Editorial (43)
Employer branding (17)
Employer resources (140)
Events (76450)
Executive appointments (662)
FDA (15948)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (696)
Gene editing (102)
Generative AI (24)
Gene therapy (313)
GLP-1 (770)
Government (4363)
Grass and pollen (4)
Guidances (65)
Healthcare (16603)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (131)
Indications (28)
Infectious disease (2753)
Inflammatory bowel disease (123)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (89)
Interviews (535)
IPO (14012)
IRA (45)
Job creations (3610)
Job search strategy (1961)
Kidney cancer (10)
Labor market (36)
Layoffs (530)
Leadership (22)
Legal (8097)
Liver cancer (65)
Lung cancer (310)
Lymphoma (156)
Machine learning (7)
Management (58)
Manufacturing (317)
MASH (68)
Medical device (11774)
Medtech (11778)
Mergers & acquisitions (16141)
Metabolic disorders (706)
Multiple sclerosis (77)
NASH (20)
Neurodegenerative disease (101)
Neuropsychiatric disorders (33)
Neuroscience (1903)
NextGen: Class of 2025 (5999)
Non-profit (4386)
Now hiring (28)
Obesity (382)
Opinion (259)
Ovarian cancer (70)
Pain (94)
Pancreatic cancer (82)
Parkinson's disease (146)
Partnered (21)
Patents (234)
Patient recruitment (106)
Peanut (44)
People (46846)
Pharmaceutical (30)
Pharmacy benefit managers (20)
Phase I (16443)
Phase II (24172)
Phase III (19541)
Pipeline (1190)
Policy (161)
Postmarket research (2146)
Preclinical (6462)
Press Release (67)
Prostate cancer (103)
Psychedelics (36)
Radiopharmaceuticals (211)
Rare diseases (368)
Real estate (5658)
Recruiting (61)
Regulatory (19861)
Reports (39)
Research institute (2350)
Resumes & cover letters (445)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (76)
Series A (113)
Series B (82)
Service/supplier (10)
Sickle cell disease (49)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3356)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (43)
The Weekly (64)
Vaccines (709)
Venture capitalists (42)
Weight loss (275)
Women's health (35)
Worklife (18)
Date
Today (26)
Last 7 days (701)
Last 30 days (2163)
Last 365 days (28589)
2025 (9462)
2024 (30787)
2023 (34609)
2022 (45041)
2021 (48838)
2020 (47740)
2019 (41961)
2018 (31937)
2017 (28885)
2016 (27727)
2015 (31841)
2014 (25180)
2013 (22002)
2012 (21083)
2011 (21730)
2010 (18926)
Location
Africa (835)
Alabama (48)
Alaska (5)
Arizona (141)
Arkansas (12)
Asia (35088)
Australia (5969)
California (5012)
Canada (1821)
China (477)
Colorado (242)
Connecticut (238)
Delaware (119)
Europe (79347)
Florida (817)
Georgia (186)
Idaho (53)
Illinois (496)
India (24)
Indiana (264)
Iowa (8)
Japan (157)
Kansas (90)
Kentucky (21)
Louisiana (12)
Maine (65)
Maryland (707)
Massachusetts (3439)
Michigan (207)
Minnesota (290)
Mississippi (2)
Missouri (81)
Montana (25)
Nebraska (21)
Nevada (60)
New Hampshire (63)
New Jersey (1573)
New Mexico (26)
New York (1538)
North Carolina (875)
North Dakota (8)
Northern California (2175)
Ohio (193)
Oklahoma (10)
Oregon (31)
Pennsylvania (1173)
Puerto Rico (11)
Rhode Island (27)
South America (1205)
South Carolina (21)
South Dakota (1)
Southern California (1849)
Tennessee (81)
Texas (782)
United States (19343)
Utah (183)
Virginia (138)
Washington D.C. (54)
Washington State (481)
West Virginia (3)
Wisconsin (42)
572,341 Results for "la biomed".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
April 28, 2025
·
2 min read
Layoffs
Lyell Cuts 73 Employees as Part of LA Site Closure
After moving the manufacturing of a CAR T drug that was part of its ImmPACT Bio acquisition to Washington, Lyell Immunopharma is closing its Los Angeles manufacturing facility, eliminating dozens of jobs there.
April 7, 2025
·
1 min read
·
Angela Gabriel
Press Releases
RESTEM to Participate in Jones Las Vegas Technology and Innovation Conference
April 2, 2025
·
1 min read
Press Releases
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
April 23, 2025
·
10 min read
Press Releases
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies
March 12, 2025
·
3 min read
Press Releases
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer
April 9, 2025
·
3 min read
Press Releases
Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
April 18, 2025
·
5 min read
Press Releases
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split
May 1, 2025
·
5 min read
Press Releases
NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th
April 7, 2025
·
1 min read
Press Releases
Harbour BioMed Reports Full Year 2024 Financial Results
April 1, 2025
·
14 min read
1 of 57,235
Next
